Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

31.09
Delayed Data
As of 4:00pm ET
 +0.55 / +1.80%
Today’s Change
18.55
Today|||52-Week Range
245.82
-69.41%
Year-to-Date
Today's Good, Bad and Ugly
2:31pm / TheStreet.com - Paid Partner Content
Healthcare Drug Pricing a Factor for the Market on Wednesday
Aug 24 / GuruFocus News - Paid Partner Content
Here's A Reason Why Valeant (VRX) Stock Is Climbing Today
11:19am / TheStreet.com - Paid Partner Content
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
Aug 24 / TheStreet.com - Paid Partner Content
Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny
10:44am / TheStreet.com - Paid Partner Content
Crude Oil, Health Care Team Up to Pull Wall Street Lower
Aug 24 / TheStreet.com - Paid Partner Content
EpiPen CEO: Blame the 'broken' system, not me
10:04am / CNNMoney.com
4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnar...
Aug 23 / MotleyFool.com - Paid Partner Content
Mallinckrodt's Top Drug Could Go the Way of EpiPen
8:43am / TheStreet.com - Paid Partner Content
Stock Market News for August 23, 2016
Aug 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close30.54
Today’s open31.09
Day’s range30.40 - 32.15
Volume39,696,774
Average volume (3 months)30,776,816
Market cap$10.4B
Dividend yield--
Data as of 4:00pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-35.41%
Earnings growth (next 5 years)+10.35%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.77

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-3.90-4.93%
PRGOPerrigo Company PLC+0.63+0.72%
JAZZJazz Pharmaceuticals...-2.60-2.00%
RDYDr.Reddy's Laborator...+0.32+0.71%
Data as of 4:02pm ET, 08/25/2016

Financials

Next reporting dateOctober 17, 2016
EPS forecast (this quarter)$1.79
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts

Partner Offers

Search for Jobs